Rocket One Inc. SEC filings RKTO
Rocket One Inc. has 352 filings in SEC EDGAR's recent list, going back to Jul 14, 2017. Its latest annual report, Form ARS, was filed on Oct 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 23, 2026 | Dec 17, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2026 | Oct 2, 2026 |
| DEFA14A | Additional proxy material | Jun 16, 2025 | — |
| DEF 14A | Proxy statement | Jun 16, 2025 | Aug 5, 2025 |
| DEFA14A | Additional proxy material | Jun 18, 2024 | — |
| DEF 14A | Proxy statement | Jun 18, 2024 | Aug 7, 2024 |
| DEFA14A | Additional proxy material | Jun 27, 2023 | — |
| DEF 14A | Proxy statement | Jun 27, 2023 | Aug 18, 2023 |
| DEFA14A | Additional proxy material | Nov 14, 2022 | — |
| DEF 14A | Proxy statement | Nov 14, 2022 | Dec 12, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 3, 2022 | Nov 3, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 15, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2022 | Apr 4, 2022 |
| DEF 14A | Proxy statement | May 7, 2021 | Jun 24, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2021 | Apr 26, 2021 |
| DEF 14A | Proxy statement | May 19, 2020 | Jun 30, 2020 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RKTO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Hoboken, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1711786
- Former names
- Hoth Therapeutics, Inc. (until May 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.